Therapy for acute pancreatitis with platelet-activating factor receptor antagonists

World Journal of Gastroenterology

Volumn 14, Issue 30, 2008, Pages 4735-4738

  Chen, Chong ^a   Xia, Shi Hai ^a   Chen, Hong ^a   Li, Xiao Hong ^b  

^a MEDICAL COLLEGE OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

^b Wuhan Command School of Armed Police Force   (China)

Author keywords

Acute pancreatitis; BN52021; Lexipafant; Platelet activating factor; Platelet activating factor receptor antagonist

Indexed keywords

3 BROMO 5 [N PHENYL N [2 [[2 (1,2,3,4 TETRAHYDRO 2 ISOQUINOLYLCARBONYLOXY)ETHYL]CARBAMOYL]ETHYL]CARBAMOYL] 1 PROPYLPYRIDINIUM NITRATE; APAFANT; BEPAFANT; GINKGOLIDE B; LEXIPAFANT; PLACEBO; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; ANTIINFLAMMATORY AGENT; ANTITHROMBOCYTIC AGENT; AZEPINE DERIVATIVE; DRUG DERIVATIVE; FIBRINOGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GINKGOLIDE; IMIDAZOLE DERIVATIVE; LACTONE; LEUCINE; PYRIDINIUM DERIVATIVE; TETRAHYDROISOQUINOLINE DERIVATIVE; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TRIAZOLE DERIVATIVE;

ACUTE PANCREATITIS; CLINICAL TRIAL; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG TARGETING; HUMAN; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; ACUTE DISEASE; ANIMAL; DRUG ANTAGONISM; METABOLISM; PANCREATITIS; TREATMENT OUTCOME;

ACUTE DISEASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; AZEPINES; GINKGOLIDES; HUMANS; IMIDAZOLES; LACTONES; LEUCINE; PANCREATITIS; PLATELET AGGREGATION INHIBITORS; PLATELET MEMBRANE GLYCOPROTEINS; PYRIDINIUM COMPOUNDS; RECEPTORS, G-PROTEIN-COUPLED; TETRAHYDROISOQUINOLINES; TREATMENT OUTCOME; TRIAZOLES;

EID: 55449132205     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.4735     Document Type: Review

References (34)

1. Xin MJ, Chen H, Luo B, Sun JB. Severe acute pancreatitis in the elderly: Etiology and clinical characteristics. World J Gastroenterol 2008; 14: 2517-2521
2. Malangoni MA, Martin AS. Outcome of severe acute pancreatis. Am J Surg 2005; 189: 273-277.
3. Kingsnorth AN. Platelet-activating factor. Scand J Gastroenterol Suppl 1996; 219: 28-31
4. Johnson CD. Platelet-activating factor and platelet-activating factor antagonists in acute pancreatitis. Dig Surg 1999; 16: 93-101
5. Ramos G, Kazimi N, Nghiem DX, Walterscheid JP, Ullrich SE. Platelet activating factor receptor binding plays a critical role in jet fuel-induced immune suppression. Toxicol Appl Pharmacol 2004; 195: 331-338
6. Fragopoulou E, Iatrou C, Antonopoulou S, Ruan XZ, Fernando RL, Powis SH, Moorhead JF, Varghese Z. Platelet-activating factor (PAF) increase intracellular lipid accumulation by increasing both LDL and scavenger receptors in human mesangial cells. J Lab Clin Med 2006; 147: 281-289
7. Zinchuk O, Fukushima A, Zinchuk V, Fukata K, Ueno H. Direct action of platelet activating factor (PAF) induces eosinophil accumulation and enhances expression of PAF receptors in conjunctivitis. Mol Vis 2005; 11: 114-123
8. Yoshida H, Imaizumi T, Tanji K, Sakaki H, Metoki N, Hatakeyama M, Yamashita K, Ishikawa A, Taima K, Sato Y, Kimura H, Satoh K. Platelet-activating factor enhances the expression of nerve growth factor in normal human astrocytes under hypoxia. Brain Res Mol Brain Res 2005; 133: 95-101
9. Ersoy B, Huseyinov A, Darcan S. The role of platelet-activating factor in pathogenesis of type 1 diabetes. Diabetes Care 2005; 28: 980
10. Grypioti AD, Theocharis SE, Papadimas GK, Demopoulos CA, Papadopoulou-Daifoti Z, Basayiannis AC, Mykoniatis MG. Platelet-activating factor (PAF) involvement in acetaminophen-induced liver toxicity and regeneration. Arch Toxicol 2005; 79: 466-474
11. Zazzo JF. [Nutrition in acute pancreatitis] Schweiz Med Wochenschr 1999; 129: 1617-1625
12. Soling HD, Eibl H, Fest W. Acetylcholine-like effects of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine ('platelet-activating factor') and its analogues in exocrine secretory glands. Eur J Biochem 1984; 144: 65-72
13. Emanuelli G, Montrucchio G, Gaia E, Dughera L, Corvetti G, Gubetta L. Experimental acute pancreatitis induced by platelet activating factor in rabbits. Am J Pathol 1989; 134: 315-326
14. Le Bars PL. Magnitude of effect and special approach to Ginkgo biloba extract EGb 761 in cognitive disorders. Pharmacopsychiatry 2003; 36 Suppl 1: S44-S49
15. Ewer AK, Al-Salti W, Coney AM, Marshall JM, Ramani P, Booth IW. The role of platelet activating factor in a neonatal piglet model of necrotising enterocolitis. Gut 2004; 53: 207-213
16. Souza LJ, Shio MT, Molan NA, Machado MC, Jancar S. Acute pancreatitis affects non-parenchymal liver cells by a mechanism dependent on platelet-activating factor. Pancreatology 2007; 7: 67-73
17. Wang S b, Tang YL, Yang YZ, Xu ZX, Peng K. Opposite effects of WEB2086 on angiogenesis in atheromas and ischemic hindlimb of apoE gene deficient mice. Chin Med J (Engl) 2007; 120: 886-892
18. Yamaguchi Y, Matsumura F, Liang J, Okabe K, Matsuda T, Ohshiro H, Ishihara K, Akizuki E, Yamada S, Ogawa M. Platelet-activating factor antagonist (TCV-309) attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats. Pancreas 1999; 18: 355-363
19. Aldemir M, Bosnak M, Al B, Buyukbayram H, Tacyildiz I. Effects of molsidomine and lexipafant in hepatic ischaemia-reperfusion injury. Injury 2004; 35: 232-237
20. Ozturk H, Ozturk H, Dokucu AI, Otcu S. Effects of lexipafant (BB-882), a platelet activating factor receptor antagonist, on liver damage due to bile duct ligation in rats. Acta Gastroenterol Belg 2006; 69: 197
21. Wang X, Sun Z, Borjesson A, Haraldsen P, Aldman M, Deng X, Leveau P, Andersson R. Treatment with lexipafant ameliorates the severity of pancreatic microvascular endothelial barrier dysfunction in rats with acute hemorrhagic pancreatitis. Int J Pancreatol 1999; 25: 45-52
22. Leveau P, Wang X, Sun Z, Borjesson A, Andersson E, Andersson R. Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant. Biochem Pharmacol 2005; 69: 1325-1331
23. Lane JS, Todd KE, Gloor B, Chandler CF, Kau AW, Ashley SW, Reber HA, McFadden DW. Platelet activating factor antagonism reduces the systemic inflammatory response in a murine model of acute pancreatitis. J Surg Res 2001; 99: 365-370
24. Liu Q, Djuricin G, Rossi H, Bewsey K, Nathan C, Gattuso P, Weinstein RA, Prinz RA. The effect of lexipafant on bacterial translocation in acute necrotizing pancreatitis in rats. Am Surg 1999; 65: 611-616; discussion 617
25. Abu-Zidan FM, Windsor JA. Lexipafant and acute pancreatitis: a critical appraisal of the clinical trials. Eur J Surg 2002; 168: 215-219
26. Vincent JL, Spapen H, Bakker J, Webster NR, Curtis L. Phase II multicenter clinical study of the platelet-activating factor receptor antagonist BB-882 in the treatment of sepsis. Crit Care Med 2000; 28: 638-642
27. Johnson CD, Kingsnorth AN, Imrie CW, McMahon MJ, Neoptolemos JP, McKay C, Toh SK, Skaife P, Leeder PC, Wilson P, Larvin M, Curtis LD. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut 2001; 48: 62-69
28. Jancar S, De Giaccobi G, Mariano M, Mencia-Huerta JM, Sirois P, Braquet P. Immune complex induced pancreatitis: effect of BN 52021, a selective antagonist of platelet-activating factor. Prostaglandins 1988; 35: 757-770
29. Xia SH, Hu CX, Zhao ZL, Xia GD, Di Y. Significance of platelet activating factor receptor expression in pancreatic tissues of rats with severe acute pancreatitis and effects of BN52021. World J Gastroenterol 2007; 13: 2992-2998
30. Huang SH, Duke RK, Chebib M, Sasaki K, Wada K, Johnston GA. Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant alpha1beta2gamma2L GABAA receptors. Eur J Pharmacol 2004; 494: 131-138
31. Amri H, Drieu K, Papadopoulos V. Transcriptional suppression of the adrenal cortical peripheral-type benzodiazepine receptor gene and inhibition of steroid synthesis by ginkgolide B. Biochem Pharmacol 2003; 65: 717-729
32. Bedirli A, Gokahmetoglu S, Sakrak O, Soyuer I, Ince O, Sozuer E. Beneficial effects of recombinant platelet-activating factor acetylhydrolase and BN 52021 on bacterial translocation in cerulein-induced pancreatitis. Eur Surg Res 2004; 36: 136-141
33. Wereszczynska-Siemiatkowska U, Dlugosz JW, Siemiatkowski A, Chyczewski L, Gabryelewicz A. Lysosomal activity of pulmonary alveolar macrophages in acute experimental pancreatitis in rats with reference to positive PAF-antagonist (BN 52021) effect. Exp Toxicol Pathol 2000; 52: 119-125
34. Grypioti AD, Kostopanagiotou G, Demopoulos CA, Roussos A, Mykoniatis M. Platelet activating factor (PAF) antagonism with ginkgolide B protects the liver against acute injury. importance of controlling the receptor of PAF. Dig Dis Sci 2008; 53: 1054-1062